Bodmer JL - Search Results

1

Characterization of two receptors for TRAIL.

Schneider P, Bodmer JL, Thome M, Hofmann K, Holler N, Tschopp J. Schneider P, et al. Among authors: bodmer jl. FEBS Lett. 1997 Oct 27;416(3):329-34. doi: 10.1016/s0014-5793(97)01231-3. FEBS Lett. 1997. PMID: 9373179 Free article.

2

TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95).

Bodmer JL, Burns K, Schneider P, Hofmann K, Steiner V, Thome M, Bornand T, Hahne M, Schröter M, Becker K, Wilson A, French LE, Browning JL, MacDonald HR, Tschopp J. Bodmer JL, et al. Immunity. 1997 Jan;6(1):79-88. doi: 10.1016/s1074-7613(00)80244-7. Immunity. 1997. PMID: 9052839 Free article.

3

Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors.

Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schröter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J. Thome M, et al. Among authors: bodmer jl. Nature. 1997 Apr 3;386(6624):517-21. doi: 10.1038/386517a0. Nature. 1997. PMID: 9087414

4

Characterization of Fas (Apo-1, CD95)-Fas ligand interaction.

Schneider P, Bodmer JL, Holler N, Mattmann C, Scuderi P, Terskikh A, Peitsch MC, Tschopp J. Schneider P, et al. Among authors: bodmer jl. J Biol Chem. 1997 Jul 25;272(30):18827-33. doi: 10.1074/jbc.272.30.18827. J Biol Chem. 1997. PMID: 9228058 Free article.

5

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB.

Schneider P, Thome M, Burns K, Bodmer JL, Hofmann K, Kataoka T, Holler N, Tschopp J. Schneider P, et al. Among authors: bodmer jl. Immunity. 1997 Dec;7(6):831-6. doi: 10.1016/s1074-7613(00)80401-x. Immunity. 1997. PMID: 9430228 Free article.

6

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity.

Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A, Tschopp J. Schneider P, et al. Among authors: bodmer jl. J Exp Med. 1998 Apr 20;187(8):1205-13. doi: 10.1084/jem.187.8.1205. J Exp Med. 1998. PMID: 9547332 Free PMC article.

7

APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth.

Hahne M, Kataoka T, Schröter M, Hofmann K, Irmler M, Bodmer JL, Schneider P, Bornand T, Holler N, French LE, Sordat B, Rimoldi D, Tschopp J. Hahne M, et al. Among authors: bodmer jl. J Exp Med. 1998 Sep 21;188(6):1185-90. doi: 10.1084/jem.188.6.1185. J Exp Med. 1998. PMID: 9743536 Free PMC article.

8

BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

Schneider P, MacKay F, Steiner V, Hofmann K, Bodmer JL, Holler N, Ambrose C, Lawton P, Bixler S, Acha-Orbea H, Valmori D, Romero P, Werner-Favre C, Zubler RH, Browning JL, Tschopp J. Schneider P, et al. Among authors: bodmer jl. J Exp Med. 1999 Jun 7;189(11):1747-56. doi: 10.1084/jem.189.11.1747. J Exp Med. 1999. PMID: 10359578 Free PMC article.

9

Development of improved soluble inhibitors of FasL and CD40L based on oligomerized receptors.

Holler N, Kataoka T, Bodmer JL, Romero P, Romero J, Deperthes D, Engel J, Tschopp J, Schneider P. Holler N, et al. Among authors: bodmer jl. J Immunol Methods. 2000 Apr 3;237(1-2):159-73. doi: 10.1016/s0022-1759(99)00239-2. J Immunol Methods. 2000. PMID: 10725460 Free article.

10

Cysteine 230 is essential for the structure and activity of the cytotoxic ligand TRAIL.

Bodmer JL, Meier P, Tschopp J, Schneider P. Bodmer JL, et al. J Biol Chem. 2000 Jul 7;275(27):20632-7. doi: 10.1074/jbc.M909721199. J Biol Chem. 2000. PMID: 10748154 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page